Ulrich Mueller


Chief Business Officer

Mueller spent more than six years at Fred Hutch, where he served as VP of industry relations and clinical research support. He has 20 years of consistent achievement and advancement with broad executive management skills. While at Fred Hutch, he led the Center’s spin-out efforts to help launch companies including Juno Therapeutics, Adaptive Biotechnologies, Presage Biosciences and Blaze Biosciences. Mueller spent three years as the COO of Houston-based Bio-Path Holdings before joining SEngine.